← FDA Drug Approvals (Drugs@FDA)

EYSUVIS

NDA · New Drug Application · Sponsor: ALCON LABS INC · Approved 2020-10-26

Drug application

FDA Application #

NDA210933

Application type

New Drug Application

Brand name

EYSUVIS

Generic name

LOTEPREDNOL ETABONATE

Active ingredients

LOTEPREDNOL ETABONATE

Dosage form

SUSPENSION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

ALCON LABS INC

Manufacturer

ALCON LABORATORIES, INC.

First approval

2020-10-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown